Sequentia Biotech is supporting R&D in SARS-CoV-2 by making GAIA, its microbiome analysis software,  able to detect and analyze SARS-CoV-2 NGS data with high precision and sensitivity, in a fast and easy way.
We are committed with researchers who are constantly trying to get a better and deeper understanding of the virus and new diagnosis and therapeutics methods, that’s why we updated GAIA and delivered a powerful tool that the scientific community can rely on.
  • Detects SARS-CoV-2 with high precision and sensibility.* 
  • Performs SARS-CoV-2 strain identification, even in complex viral matrices. 
  • Updated and curated SARS-CoV-2 databases. 
  • Works with Amplicon and Shotgun sequencing. 
  • Works with any biological sample.
  • Works with data from any NGS platform (Illumina, Oxford Nanopore, PacBio, IonTorrent).
  • Optimized for Oxford Nanopore sequencing.** 

* Illumina: 100% precision; 99,2% sensitivity. Oxford Nanopore: 99,6% precision; 87,9% sensitivity.

** Improves the discrimination of chimeric reads.